CBL-514 is under clinical development by Caliway Biopharmaceutics and currently in Phase II for Adiposis Dolorosa (Dercum’s Disease or Anders Disease). According to GlobalData, Phase II drugs for ...
Some results have been hidden because they may be inaccessible to you